- Home
- CFSB vs ELEV Comparison
CFSB vs ELEV Comparison
Compare CFSB & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- ELEV
- Stock Information
- Founded
- CFSB 1889
- ELEV 2019
- Country
- CFSB United States
- ELEV United States
- Employees
- CFSB N/A
- ELEV N/A
- Industry
- CFSB Major Banks
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- ELEV Health Care
- Exchange
- CFSB Nasdaq
- ELEV Nasdaq
- Market Cap
- CFSB 44.7M
- ELEV 37.6M
- IPO Year
- CFSB N/A
- ELEV 2021
- Fundamental
- Price
- CFSB $6.75
- ELEV $0.58
- Analyst Decision
- CFSB
- ELEV Strong Buy
- Analyst Count
- CFSB 0
- ELEV 5
- Target Price
- CFSB N/A
- ELEV $7.20
- AVG Volume (30 Days)
- CFSB 8.9K
- ELEV 860.8K
- Earning Date
- CFSB 01-24-2025
- ELEV 11-06-2024
- Dividend Yield
- CFSB N/A
- ELEV N/A
- EPS Growth
- CFSB N/A
- ELEV N/A
- EPS
- CFSB N/A
- ELEV N/A
- Revenue
- CFSB $7,444,000.00
- ELEV N/A
- Revenue This Year
- CFSB N/A
- ELEV N/A
- Revenue Next Year
- CFSB N/A
- ELEV N/A
- P/E Ratio
- CFSB N/A
- ELEV N/A
- Revenue Growth
- CFSB N/A
- ELEV N/A
- 52 Week Low
- CFSB $6.21
- ELEV $0.44
- 52 Week High
- CFSB $7.95
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- CFSB 52.19
- ELEV 43.94
- Support Level
- CFSB $6.60
- ELEV $0.60
- Resistance Level
- CFSB $6.82
- ELEV $0.70
- Average True Range (ATR)
- CFSB 0.12
- ELEV 0.08
- MACD
- CFSB 0.01
- ELEV -0.01
- Stochastic Oscillator
- CFSB 79.07
- ELEV 7.67
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.